Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVID-19)

NCT04560881 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

3000

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19 Virus Infection

Interventions

BIOLOGICAL: Inactivated SARS-CoV-2 vaccine (Vero cell)
BIOLOGICAL: Placebo/Aluminum Adjuvant of Inactivated SARS-CoV-2 vaccine

Sponsor

Laboratorio Elea Phoenix S.A.

Collaborators

[object Object]
[object Object]
[object Object]